|
|
|
Insider
Information: |
Ajer Jeffrey Robert |
Relationship: |
Director |
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
100,920 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$5,977,498 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
100,920 |
|
|
Total
Value |
$5,977,498 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-1.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-05-02 |
66,767 |
|
0 |
Premium* |
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
174 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2019-03-26 |
4 |
AS |
$89.18 |
$326,025 |
D/D |
(3,656) |
47,475 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2021-09-22 |
4 |
S |
$17.78 |
$65,164 |
D/D |
(3,665) |
32,510 |
0 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2019-03-19 |
4 |
AS |
$93.07 |
$346,965 |
D/D |
(3,728) |
59,248 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-03-29 |
4 |
AS |
$89.15 |
$346,794 |
D/D |
(3,890) |
51,532 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2023-03-15 |
4 |
D |
$87.74 |
$348,416 |
D/D |
(3,971) |
85,996 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-03-04 |
4 |
OE |
$21.51 |
$86,040 |
D/D |
4,000 |
14,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-03-04 |
4 |
AS |
$60.00 |
$240,000 |
D/D |
(4,000) |
10,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2024-03-05 |
4 |
AS |
$87.07 |
$348,280 |
D/D |
(4,000) |
94,047 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2022-09-23 |
4 |
S |
$3.16 |
$13,266 |
D/D |
(4,198) |
38,512 |
0 |
% |
|
NKTR |
Nektar Therapeutics |
Director |
|
2023-09-18 |
4 |
S |
$0.69 |
$3,008 |
D/D |
(4,359) |
34,153 |
0 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2018-03-21 |
4 |
AS |
$83.90 |
$366,475 |
D/D |
(4,368) |
60,153 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-05-05 |
4 |
OE |
$28.23 |
$162,879 |
D/D |
4,486 |
55,030 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-05-05 |
4 |
AS |
$99.00 |
$444,114 |
D/D |
(4,486) |
51,532 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2019-03-21 |
4 |
AS |
$89.62 |
$406,634 |
D/D |
(4,519) |
54,729 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2018-09-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,750 |
20,500 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-04-19 |
4 |
AS |
$65.00 |
$325,000 |
D/D |
(5,000) |
10,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2013-04-19 |
4 |
OE |
$21.51 |
$107,550 |
D/D |
5,000 |
15,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2017-03-07 |
4 |
AS |
$90.56 |
$452,800 |
D/D |
(5,000) |
46,510 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2023-08-16 |
4 |
AS |
$90.00 |
$450,000 |
D/D |
(5,000) |
60,804 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2024-05-02 |
4 |
AS |
$82.91 |
$414,550 |
D/D |
(5,000) |
66,767 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2021-03-15 |
4 |
D |
$78.39 |
$413,350 |
D/D |
(5,273) |
66,728 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2012-11-28 |
4 |
OE |
$14.39 |
$106,110 |
D/D |
5,916 |
16,486 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Commercial Of |
|
2012-11-28 |
4 |
S |
$48.31 |
$285,817 |
D/D |
(5,916) |
10,570 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
|
2022-03-23 |
4 |
AS |
$81.78 |
$501,230 |
D/D |
(6,129) |
59,256 |
0 |
- |
|
NKTR |
Nektar Therapeutics |
Director |
|
2019-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
24,750 |
0 |
- |
|
174 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|